Narcolepsy is a chronic neurological condition characterized by disruptions in the regulation of sleep-wake cycles. People ...

Cataplexy is a sudden loss of muscle tone. It’s associated with a condition called narcolepsy. It can look like a seizure, but it’s not. Treatment involves medication and lifestyle changes. Cataplexy ...

SAN DIEGO — The investigational drug AXS-12 (reboxetine, Axsome Therapeutics) is safe and effective for the treatment of cataplexy (emotionally induced muscle weakness) and excessive daytime ...

Cataplexy is a sudden, brief loss of voluntary muscle tone triggered by strong emotions such as laughter, excitement, anger or fear. There is a strong association between cataplexy and narcolepsy, a ...

Cataplexy is a sudden episode of muscle weakness that occurs while fully aware and conscious. It can be triggered by emotional events, such as laughing, crying or fear, and is usually transient in ...

The US FDA has approved oveporexton (Orzeyful, Takeda), a first-in-class oral selective orexin receptor 2 agonist for the treatment of narcolepsy type 1 (NT1) in adults. NT1 is a rare, chronic ...

Cataplexy refers to episodes of muscle weakness that typically occur with narcolepsy type one — roughly 75% of people with this sleep disorder experience cataplexy. But among the general population, ...

Pitolisant is now the only treatment option not scheduled as a controlled substance that is indicated for both excessive daytime sleepiness and cataplexy in pediatric and adult patients. The Food and ...

Cataplexy is a condition that brings on brief bouts of muscle weakness or paralysis. It can happen in people living with the sleep disorder narcolepsy. Some people have an episode of cataplexy just ...